A human monoclonal antibody that specifically binds and inhibits the staphylococcal complement inhibitor protein SCIN.

Autor: Hoekstra H; a Department of Medical Microbiology , University of Groningen, University Medical Center Groningen , Groningen , The Netherlands., Romero Pastrana F; a Department of Medical Microbiology , University of Groningen, University Medical Center Groningen , Groningen , The Netherlands., Bonarius HPJ; b IQ Therapeutics , Groningen , The Netherlands., van Kessel KPM; c Medical Microbiology, University Medical Center Utrecht , Utrecht , The Netherlands., Elsinga GS; b IQ Therapeutics , Groningen , The Netherlands., Kooi N; b IQ Therapeutics , Groningen , The Netherlands., Groen H; b IQ Therapeutics , Groningen , The Netherlands., van Dijl JM; a Department of Medical Microbiology , University of Groningen, University Medical Center Groningen , Groningen , The Netherlands., Buist G; a Department of Medical Microbiology , University of Groningen, University Medical Center Groningen , Groningen , The Netherlands.

Publikováno v: Virulence [Virulence] 2018 Jan 01; Vol. 9 (1), pp. 70-82. Date of Electronic Publication: 2017 May 08.

High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus.

Autor: van der Kooi-Pol MM; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Vogel CP; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands., Westerhout-Pluister GN; Laboratory for Infectious Diseases and Perinatal Screening, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Veenstra-Kyuchukova YK; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Duipmans JC; Department of Dermatology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands., Glasner C; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Buist G; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Elsinga GS; IQ Therapeutics, Rozenburglaan 13a, Groningen, The Netherlands., Westra H; IQ Therapeutics, Rozenburglaan 13a, Groningen, The Netherlands., Bonarius HPJ; IQ Therapeutics, Rozenburglaan 13a, Groningen, The Netherlands., Groen H; IQ Therapeutics, Rozenburglaan 13a, Groningen, The Netherlands., van Wamel WJB; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands., Grundmann H; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Laboratory for Infectious Diseases and Perinatal Screening, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Jonkman MF; Department of Dermatology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands., van Dijl JM; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: J.M.van.Dijl01@umcg.nl.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2013 Mar; Vol. 133 (3), pp. 847-850. Date of Electronic Publication: 2012 Sep 27.